Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States

27 May 2021

Abstract excerpt

IMPORTANCE: The prevalence of germline pathogenic variants (PVs) in cancer susceptibility genes in US Black women compared with non-Hispanic White women with breast cancer is poorly described. OBJECTIVE: To determine whether US Black and non-Hispanic White women with breast cancer have a different prevalence of PVs in 12 cancer susceptibility genes. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, population-based...

Source

Identifiers

PMID: 34042955
DOI: 10.1001/jamaoncol.2021.1492

Provenance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesPMID 34042955Read ↗

Prevalence of BRCA1 and BRCA2 Variants in an Unselected Population of Women With Breast Cancer.Semantic proximity Read ↗

Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial.Semantic proximity Read ↗

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.Semantic proximity Read ↗

Hereditary cancer testing in a diverse sample across three breast imaging centers.Semantic proximity Read ↗

Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes.Semantic proximity Read ↗

Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer.Semantic proximity Read ↗

Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM, CHEK2, or PALB2.Semantic proximity Read ↗

Extended Multigene Panel Testing in a High-Risk Brazilian Public Health Cohort: Pathogenic Variant Prevalence and the Role of Self-Reported EthnicitySemantic proximity Read ↗

Multigene Germline Testing in Patients with DCIS vs Invasive Breast Cancer in a Large, Integrated Health Care System.Semantic proximity Read ↗

Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.Semantic proximity Read ↗

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer PatientsSemantic proximity Read ↗

Germline pathogenic variants in Asian American/Pacific Islander women with breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.